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OBJECTIVE: To evaluate the effect of ginger extract on the expression of NFκB and TNF-α in liver cancer-induced rats. 
METHODS: Male Wistar rats were randomly divided into 5 groups based on diet: i) control (given normal rat chow), ii) olive oil, 
iii) ginger extract (100mg/kg body weight), iv) choline-deficient diet + 0.1% ethionine to induce liver cancer and v) choline-deficient 
diet + ginger extract (100mg/kg body weight). Tissue samples obtained at eight weeks were fixed with formalin and embedded in 
paraffin wax, followed by immunohistochemistry staining for NFκB and TNF-α. 
RESULTS: The expression of NFκB was detected in the choline-deficient diet group, with 88.3 ± 1.83% of samples showing positive 
staining, while in the choline-deficient diet supplemented with ginger group, the expression of NFκB was significantly reduced, to 
32.35 ± 1.34% (p<0.05). In the choline-deficient diet group, 83.3 ± 4.52% of samples showed positive staining of TNF-α, which was 
significantly reduced to 7.94 ± 1.32% (p<0.05) when treated with ginger. There was a significant correlation demonstrated between 
NFκB and TNF-α in the choline-deficient diet group but not in the choline-deficient diet treated with ginger extract group.
CONCLUSION: In conclusion, ginger extract significantly reduced the elevated expression of NFκB and TNF-α in rats with 
liver cancer. Ginger may act as an anti-cancer and anti-inflammatory agent by inactivating NFκB through the suppression of the 
pro-inflammatory TNF-α. 
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INTRODUCTION
Inflammatory disorders such as gastritis, esophagitis, and 
hepatitis, which are caused not only by infectious agents such 
as viruses, bacteria and parasites but also by physical and 
chemical agents like heat, acid, cigarette smoke and foreign 
bodies, are recognized as risk factors for human cancer.1,2 
Inflammation is considered to play an important role in the 
pathophysiology of cancer. However, when inflammation 
becomes chronic or lasts too long, it can be harmful. The 
diagnosis of inflammation and its biomarkers are not 
fully understood; however, pro-inflammatory cytokines, 
chemokines, adhesion molecules and the inflammatory 
enzymes have been linked to chronic inflammation.2 
Chronic inflammation has been found to mediate a 
wide variety of diseases including cardiovascular diseases, 
diabetes, arthritis, Alzheimer’s disease, pulmonary diseases 
and autoimmune diseases. Chronic inflammation has also 
been associated with various steps involved in carcinogenesis 
as well as cellular transformation, promotion, survival, 
proliferation, invasion, angiogenesis and metastasis.2-4 
During the carcinogenesis process, tumor-infiltrating 
inflammatory cells produce various types of cytokines. 
It has been proposed that pro-inflammatory cytokines 
including TNF-α, IL 1β, IL- 6 and interferon-γ contribute 
to carcinogenesis by influencing the survival, growth, 
mutation, proliferation, differentiation and movement of 
808
CLINICS 2008;63(6):807-13Anti-inflammatory effect of ginger extract on hepatocarcinoma
Habib SHM et al.
tumor cells.5 Many pro-inflammatory cytokines can activate 
the transcriptional factor NFκB, while some of the effects 
of pro-inflammatory cytokines may be mediated through the 
NFκB pathway.6-8
TNF-α is one of the pro-inflammatory cytokines and 
is a major inducer of NFκB. TNF-α has been implicated 
in tumor promotion in various experimental models 
of carcinogenesis.3,8 The incidence and multiplicity of 
papilloma in a two-stage mouse skin carcinogenesis model 
were found to be lowered in TNF-α -/- animals as compared 
with mice over-expressing TNF-α.9 TNF-α, interleukins, 
COX-2, and other chemokines can also be regulated by the 
transcriptional factor NFκB. Although this factor is expressed 
in an inactive state in most cells, cancer cells expressed an 
activated form of NFκB, which was induced by various 
inflammatory stimuli and carcinogens.10 Many studies 
have linked the NFκB signaling pathway and its regulation 
with the inflammatory response.10, 11 Thus, inhibiting the 
NFκB signaling pathway might be a therapeutic strategy in 
conjunction with the usage of chemopreventive agents such 
as ginger.12,13 
Ginger has long been used in traditional medicine as a 
cure for some diseases including inflammatory diseases.14 
Ginger contains active phenolic compounds such as 
gingerol, paradol and shogoal that have antioxidant,15 
anti-cancer,16 anti-inflammatory,17 anti-angiogenesis18 and 
anti-artherosclerotic properties.19 It has also been shown 
to down-regulate NF-κB-regulated gene products involved 
in cellular proliferation and angiogenesis, including IL-8,20 
VEGF21 and ovarian cancer cells.22
In the present study, we tested the potential anti-
inflammatory and anti-cancer effects of ginger extract 
by using an immunohistochemistry technique to detect 
the presence of the inflammatory marker TNF-α and the 
transcription factor NFκB and to observe the correlation 
between these two factors in liver carcinogenesis.
MATERIALS AND METHODS
Animals, Chemicals and Treatment
Male Wistar albino rats aged 3-4 months and weighing 
200-250 g were supplied by the Animal Care Unit of 
Universiti Kebangsaan Malaysia (UKM), Kuala Lumpur, 
Malaysia. The study was approved by the Animal Ethics of 
Faculty of Medicine, Faculty of Medicine, UKM. Animals 
were kept in pairs in polycarbonate cages and provided with 
food and water ad libitum. They were maintained under 
standard conditions of temperature and humidity with an 
alternating light and dark cycle. Rats were randomized 
into five groups of six animals each. The first group and 
the second group served as control groups and were fed 
with normal rat chow (Gold Coin, Malaysia) and olive oil, 
respectively. The latter served as a control for the gavage 
method and the delivery of ginger. Rats in group 3 received 
ginger extract at 100 mg/kg body weight by the gavage 
method. Ginger extract was prepared by ethanol extraction 
and kept at 40C. It was dissolved in olive oil and force-fed 
to the rats. Rats in group 4 were fed with a choline-deficient 
diet (ICN Biochemicals, USA) plus 0.1 % ethionine (Sigma 
Chemical Co., USA) in drinking water; this is known as 
the CDE diet. This is the model to induce the production 
of oval cells, which are the precursor cells of liver cancer23. 
Rats in group 5 received ginger as in group 3 plus the CDE 
diet. All rats were killed at eight weeks for the observation 
of liver tumor incidence, and the liver tissues were excised 
after perfusion and embedded in paraffin blocks for 
immunohistochemistry staining. 
Liver perfusion and preparation for paraffin blocks
The rats were sacrificed using ether. All equipments for 
dissection were sterilized using 70% alcohol before use. 
The rats were anesthetized intraperitoneally with Zoletil 50 
(0.1 ml/100g body weight), followed by heparin (25, 000 
U/ml) injection to the inferior vena cava. The portal vein 
was then canulated using an intravenous catheter, size 16 
G (2.25 inches) for the perfusion procedure. The liver was 
then perfused in PBS, pH 7.4, for one minute at a 10ml/
min flow rate at room temperature, followed by 1:1 ratio of 
4% paraformaldehyde and 0.1% glutaraldehyde for three 
minutes. Then the liver was perfused in PBS for another two 
minutes. A portion of the perfused liver was then immersed 
in 10% formalin for fixation before embedding in paraffin.
Preparation of tissues sections
The paraffin-embedded tissues were cut 3μm thick with 
Leica RM2135 rotation microtome (Leica, Germany). The 
tissue sections were placed on poly-L-Lysine (Sigma-Aldrich 
Co. USA)-treated slides with 1:10 dilution. The slides were 
then dried overnight and stored at room temperature until 
being used for staining. 
General protocol for immunohistochemistry staining
The sections were deparaffinized and hydrated by 
sequential immersion in xylene, graded alcohol solutions 
(100%, 95%, 80% and 70%) for three minutes at each 
concentration and running water for three minutes. Then 
sections were incubated in 3% hydrogen peroxide for 10 min 
to block the activity of endogenous peroxidases. Sections 
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were washed with TRIS-HCl-buffered saline (TBS) before 
immersion in Target Retrieval Solution (TRS) (DAKO, 
U.S.A.) for 20 minutes in a water bath at 98oC. The TRS 
solution could be either in high pH, where it ranged from 
9.8 to 9.9 or low pH, with a range of 6.0 to 6.2. The slides 
with TRS solution were left at room temperature for 20 
minutes before being washed with TBS three times for three 
minutes each. To reduce the background staining, the slides 
were immersed in Biotin and avidin solution for 30 minutes. 
The sections were then further blocked with Bovine Serum 
Albumin (BSA) to reduce the non-specific staining, followed 
by one hour of incubation with the primary antibody at 
different concentrations (1:50, 1:100, 1:200, 1: 400, 1:500, 
1:600 and 1:1000) at room temperature or overnight at 4oC. 
The sections were washed three times with TBS for three 
minutes each before incubating for 30 minutes with the 
secondary antibody conjugated with biotin and subsequently 
with Streptavidin-HRP (anti-mouse, anti-rabbit and anti-
rat LSAB + System-HRP kit, DAKO, USA). The sections 
were washed again with TBS before finally incubating with 
DAB for 10 minutes. The sections were counterstained with 
Meyer’s Hematoxylin and mounted with DPX for viewing 
of the slides.
NFκB immunohistochemistry staining
Cervical cancer tissues obtained from the Department of 
Pathology, University Kebangsaan Malaysia Medical Center 
(UKMMC), served as the positive and negative controls. The 
optimum concentration of the primary antibody (polyclonal 
rabbit anti-human Nuclear Factor kappa B, Santa Cruz 
Biotechnology, Inc.) for NFκB was found to be 1:500 for 
one hour of incubation at room temperature using low pH 
Target Retrieval Solution (TRS) (DAKO, USA). 
TNF-α immunohistochemistry staining
Breast cancer tissues obtained from the Department of 
Pathology, University Kebangsaan Malaysia Medical Center 
(UKMMC), served as the positive and negative controls. The 
optimum concentration of the primary antibody (polyclonal 
rabbit anti-mouse Tumour Necrosis Factor-alpha, Hycult 
Biotechnology) for TNF-α was found to be 1:100 for one 
hour of incubation at room temperature using high pH Target 
Retrieval Solution (TRS) (DAKO, USA). 
Immunostaining analysis 
Immunoreactivity evaluation was based on percentage of 
positive staining of NFκB and TNF-α. The mean percentage 
of positive-staining cells was determined by counting 1000 
stained cells at 10 different fields observed under 400X 
magnification using a light microscope.
Statistical analysis
Data obtained were analyzed using the SPSS 11.0 
program. Results are presented as mean + SD. The one-way 
ANOVA test was used, with p <0.05 regarded as significant. 
Pearson correlation analysis was carried out to determine the 
relationship between NFκB and TNF-α in both the CDE and 
the CDE-treated ginger group.
RESULTS
Liver tumor incidence and body weights of rats
Table 1 summarizes the incidence of liver neoplasms in 
rats on a low lipotrope diet with ethionine in drinking water 
and the effect of ginger on cancer incidence. There were no 
liver nodules in either the control groups (normal rat chow 
and olive oil) or the ginger treated rats. However, in CDE 
rats the pre-neoplastic nodules incidence was 100% and the 
average size of the nodules was 0.5-1 cm. Ginger treatment 
to CDE rats lowered the liver nodules incidence to 17%. 
Table 2 summarizes the body weights of rats under 
Table 1 - Effect of Ginger on the incidence of liver neoplasms in ethionine induced rat hepatocarcinogenesis. The forma-
tion of preneoplastic liver nodules was induced in rats by feeding them with a choline-deficient diet supplemented with 0.1 
ethionine in drinking water. Ginger extract at 100 mg/kg body weight (dissolved in olive oil) was force-fed to rats. Rats were 
killed at eight weeks, as described in the Materials and Method section, for the observation of liver nodules
Group Number of rats examined Number of rats with tumors Incidence of tumor (%) ** Tumor size (cm)
Control 6 0 0 0
CDE 6 6 100 1
Olive oil 6 0 0 0
Ginger* 6 0 0 0
Ginger + CDE 6 1 17 0.1
* 100 mg/kg body weight; **Calculated by dividing the number of rats with preneoplastic nodules by the total number of rats in the group
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different diet conditions. With the exception of the CDE 
group, all other groups showed significant elevations of body 
weight at eight weeks compared with those at the 0 week. 
However, CDE rats showed reduced body weights due to the 
carcinogen diet, which had altered the rats’ metabolism and 
reduced their appetite for food.
Oval cells
Figure 1A shows the normal morphology of hepatocytes, 
Kupfer cells and sinusoids lining the control group, while 
Figure 1B showed abnormal morphology of liver tissues 
in the CDE group with the presence of numerous oval cells 
(scanty cytoplasm with large nucleus), which are precursors 
of liver cancer cells.
NFκB staining
Figure 2a showed positive NFkB staining in the control 
cervical cancer tissue. Figures 2b and 2c show the control 
group and the group of rats supplemented with ginger 
extract. Neither group showed any expression of NFκB. 
However, the liver cancer-induced group (CDE)(Figure 2d, 
Figure 3) showed increased expression of NFκB (88.3%), 
while the ginger extract-supplemented group showed 
significantly reduced expression (32.4%, p < 0.05) (Figure 
2e, Figure 3).
TNF-α staining 
Figure 4a showed positive staining for TNF-α. in the 
positive control of breast cancer tissue. Figures 4b and 4c 
show the control group and the group of rats supplemented 
with ginger extract. Neither group showed any expression 
of TNF-α. However, the liver cancer-induced group (CDE) 
Table 2 - Weight of rats with different diet treatment
Diet treatment Week 0 body wt (g) Week 8 body wt (g)*
Control 238.11 ± 5.44 313.73 ± 7.77
CDE 240.21 ± 2.19 222.41 ± 4.76
Olive oil 239.59 ± 4.52 300.58 ± 10.89a
Ginger 
(100mg/kg body wt)
239.58 ± 4.52 303.10 ± 6.27a
CDE + Ginger 
(100mg/kg body wt)
239.74 ± 2.23 259.96 ± 9.09a
Data shows Mean ± S.D.; * = significantly different (p<0.001) compared 
to week 0 for the same group
Figure 1 - H & E staining on liver tissue of (A) control group (given a 
normal diet) (B) CDE group without treatment of CV (liver cancer was 
induced with 0.1% ethionine in drinking water plus a choline-deficient diet). 
H: Hepatocyte, K: Kuppfer cell, PV: Portal vein, S: Sinusoid, O: Oval cell 
(magnification x400)
Figure 2 - Immunohistochemical expression of NFkB. (A) Positive NFκB 
staining in cervical cancer tissue at optimum concentration of 1:500, (B) 
Control group (C) Ginger extract group, (D) Choline deficient diet with 
ethionine in drinking water, CDE group and (E) CDE + ginger extract (100 
mg/kg body wt) group. The arrows indicate positive staining of NFkB (400x). 
OV: oval cells; H: hepatocytes; S: sinosoids; VP; vena portal (x400)
Figure 3 - The effect of ginger extract on NFkB expression in liver cancer-
induced rats. The graph shows the positive expression of NFkB based on 
the different diets given. A = p ≤ 0.05 compared with eight-week control 
group; b = p ≤ 0.05 compared with olive oil group; c = p ≤ 0.05 compared 
with ginger group; d = p ≤ 0.05 compared with liver cancer induced group 
(CDE); e = p ≤ 0.05 compared with CDE+ginger group 
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(Figure 4d, Figure 5) showed increased expression of TNF-α 
(83.3%), which was reduced significantly (7.9%, p < 0.05) 
with ginger extract supplementation (Figure 4e, Figure 5).
Correlation between TNF-α and NFκB staining
There was a significant correlation (r = 0.8776) 
demonstrated between NFκB and TNF-α in the CDE group 
(p < 0.01) but not in the CDE + ginger group (Figures 6a and 
6b, respectively).
DISCUSSION 
There are numerous lines of evidence that suggest that 
nuclear factor NFκB, a pro-inflammatory transcription 
factor, could promote tumorigenesis after being activated by 
inflammatory agents, carcinogens and tumor promoters.7 It is 
constitutively active in most tumor cells, and its suppression 
in these cells leads to inhibition of proliferation, arrest 
of cell cycle and apoptosis.24 In the last few years, work 
from several groups of researchers provided a causal link 
between active constitution of NFκB and liver neoplastic 
progression.25 Hepatocellular carcinoma (HCC) is the fifth 
most common malignancy in the world and is the third most 
common cause of cancer-related death worldwide.26 
Accumulating evidence suggests that many dietary 
factors may be used alone or in combination with traditional 
chemotherapeutic agents to prevent or treat cancer. The main 
advantage of using natural or dietary compounds as an anti-
cancer remedy is that they seem to have low toxicity and show 
very few adverse side effects. Recently, some plant products 
have been studied for their possible action as inhibitors of the 
NFkB pathway. Ginger (Zingiber officinale) is widely used 
all over the world as a spice and condiment in daily cooking. 
It is a natural food component with many active phenolic 
compounds such as shagaol and gingerol, and it has been 
shown to have anti-cancer and antioxidant effects.12 We have 
shown here that ginger extract was able to reduce the incidence 
of liver neoplasms in rats; in addition, to our knowledge, this 
is the first study reporting that the anti-cancer effect exhibited 
by ginger on liver cancer cells is mediated by inflammatory 
markers NFκB and TNF-α. Oval cell proliferation precedes 
Figure 4 - Immunohistochemical expression of TNF-α. (A) Positive control 
for TNF-α staining in breast cancer tissue at optimum concentration of 1:100; 
(B) Control group; (C) Ginger extract group; (D) CDE group; and (E) CDE + 
ginger extract group. The arrows indicate positive staining of TNF-α (400x). 
OV: oval cells; H: hepatocytes; S: sinosoids; VP; vena portal
Figure 5 - The effect of ginger extract on TNF-α expression in rats with 
induced liver cancer. The graph shows the positive expression of TNF-α based 
on the different diets given. a = p ≤ 0.05 compared with eight-week control 
group; b = p ≤ 0.05 compared with olive oil group; c = p ≤ 0.05 compared 
with ginger group; d = p ≤ 0.05 compared with CDE group; e = p ≤ 0.05 
compared with CDE+ginger group
Figure 6 - Correlation coefficient between NFkB and TNF-α expressions 
in (A) CDE group and in (B) CDE supplemented with ginger extract (100 
mg/kg body weight) group. Significant correlation was observed between 
NFkB and TNF-α in CDE group (r = 0.8776, p < 0.01) but not in the CDE 
group treated with ginger extract
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neoplasia in many rodent models of hepatocellular carcinoma, 
and prevention of this proliferative response can reduce the 
risk of subsequent carcinoma.23 
We have shown here that ginger extract was able to block 
the elevated expression of NFκB in liver cancer-induced rats. 
Similarly, elevated expression of TNF-α in liver cancer rats 
was also blocked when treated with ginger extract (100mg/
kg body weight). It is apparent that ginger may act as an 
anti-cancer and anti-inflammatory agent by blocking the 
activation of NFκB via the suppression of pro-inflammatory 
cytokine, TNF-α.17 Other, similar reports have also shown 
the inhibitory effect of ginger on the NFκB pathway: 
topical application of 6-gingerol inhibited TPA-induced 
COX-2 expression and suppressed NFκB DNA binding 
activity in mice skin.13, 27 The natural active compounds in 
ginger (gingerols and zerumbone) have been found to be 
potent inhibitors for NFκB and pro-inflammatory cytokine 
TNF-α. Ginger may block any one or more steps in the 
NFκB signaling pathway, such as the signals that activate 
the NFκB signaling cascade, translocation of NFκB into 
the nucleus, DNA binding of dimers or interactions with 
the basal transcriptional machinery.28 Inhibiting the activity 
of NFκB, will subsequently inhibit growth of tumor cells 
and block metastasis and angiogenesis. The 6-gingerol 
and 6-paradol have been reported to possess a strong anti-
inflammatory activity and to suppress the TNF-α production 
in TPA-treated female ICR-mice and rats.12, 27
The activation of the TNF-α gene causes the release of 
pro-inflammatory cytokines, and this would activate the 
transcriptional factor NFκB. Activation of NFκB would 
activate the expression of other inflammatory cytokines 
such as COX-2, LOX-2, other chemokines and iNOS, which 
would lead to carcinogenesis.29 Although no significant 
correlation between NFκB and TNF-α was found in CDE 
rats treated with ginger extract, we did show a significant 
correlation of these two inflammatory markers in rats 
induced with liver cancer. A possible explanation could be 
the few samples (12 slides) representing each treatment. 
In conclusion, we have shown here that in liver cancer 
cells, NF-κB is constitutively activated and that blocking 
NFκB activation with ginger resulted in suppressed 
production of NFκB and TNF-α. This is in line with findings 
that many of the pathways that mediate adaptive survival 
strategies in cancer cells are under the transcriptional 
control of NFκB.30 Thus, the ginger extract may have a 
chemotherapeutic effect in the treatment of liver cancer. 
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